ACE2 and inflammatory bowel disease: Further studies addressing which species of ACE2 and TMPRSS2 could be altered in plasma from IBD patients infected by SARS-CoV2 can improve our knowledge about the role of these proteins in virus infectivity and whether this condition confers high susceptibility to SARS-CoV-2 cell entry.